论文部分内容阅读
目的探究阿托伐他汀联合曲美他嗪治疗冠心病患者,观察其临床疗效。方法随机抽取郑州二砂医院的80例冠心病患者进行研究与分析,按照随机分配表的方式分为试验组与对照组,每组分别为40例。对照组被进行单纯曲美他嗪治疗,试验组给予阿托伐他汀联合曲美他嗪治疗手法,观察治疗后患者的心绞痛发病次数、持续时间以及治疗过程中的不良情况。结果通过治疗后的所有患者身体状况均有所改善,但实施阿托伐他汀联合曲美他嗪治疗手法小组的患者恢复较快,心绞痛次数较对照组少,且治疗过程中不良反应也较少,试验组的总有效率明显高于对照组的总有效率,具有统计学意义(P<0.05)。结论对于冠心病患者来说,使用阿托伐他汀联合曲美他嗪治疗手法治疗该病症,安全性较高,且临床效果较好,降脂疗效明显,改善患者的心功能,值得在临床上大力推广。
Objective To investigate the clinical efficacy of atorvastatin combined with trimetazidine in patients with coronary heart disease. Methods Eighty patients with coronary heart disease in Zhengzhou Second Sand Hospital were randomly divided into trial group and control group according to randomized distribution table, with 40 cases in each group. The control group was treated with trimetazidine alone. The trial group was given atorvastatin combined with trimetazidine treatment, and the incidence of angina pectoris, the duration of the treatment and the adverse reactions during the treatment were observed. Results All patients treated showed improvements in their physical status, but patients who underwent atorvastatin combined with trimetazidine recovered faster and had fewer angina pectoris and fewer adverse reactions during treatment , The total effective rate of the experimental group was significantly higher than the total effective rate of the control group, with statistical significance (P <0.05). Conclusion For patients with coronary heart disease, the use of atorvastatin combined with trimetazidine treatment of the disease to treat the disease, the safety is higher, and the clinical effect is better, lipid-lowering effect is obvious to improve the patient’s cardiac function, it is clinically Promote.